Tag: pharmaceuticals
-

Start-Up Developing Thin Films for Vaccine Delivery
A new enterprise is creating thin films for vaccines, including Covid-19, to make possible their mass production and distribution at room temperatures.
-

DoD Funds Covid-19 G.I. Infection Therapy
A biotechnology company is developing biologic treatments for Covid-19 infections in the gastrointestinal tract and to block further disease transmission.
-

Chip-Based RNA Biotech Raises $60M in Venture Funds
A company developing messenger RNA therapeutics on demand from single-use biochips is raising $60 million in its second venture funding round.
-

Skeletal Stem Cells Enhanced for Bone Repair
Researchers in the U.K. created a bandage with enhanced human skeletal stem cells that in lab mice repairs simulated skull defects.
-

Mental Health Drug Company Raises $127.5M in IPO
A company developing a drug for depression based on synthesized compounds in hallucinogenic substances is raising $127.5 million in its initial public stock offer.
-

Biotechs Partner on Gene-Editing Cystic Fibrosis Therapy
Two biotechnology companies are adding to their current collaboration to develop delivery techniques for gene-editing treatments for cystic fibrosis.
-

Early Trial Results Show Antibody Treating Covid-19
First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days.
-

Precision Cancer Therapy Start-Up Gains $110M in Early Funds
A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round.
-

Gilead Acquires Cancer Therapy Biotech for $21B
Gilead Sciences is acquiring biotechnology company Immunomedics, specializing in immunotherapies for cancer and other diseases, in a deal valued at $21 billion.
-

NIH Trials Testing Covid-19 Blood Clot Therapies
National Institutes of Health is starting two clinical trials testing a number of blood thinning treatments for people with blood clots from Covid-19 infections.